Page last updated: 2024-08-16

resveratrol and Deafness, Transitory

resveratrol has been researched along with Deafness, Transitory in 6 studies

Research

Studies (6)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's5 (83.33)24.3611
2020's1 (16.67)2.80

Authors

AuthorsStudies
Chen, Z; Dong, H; Fang, J; Mao, S; Shi, H; Su, K; Wu, H; Xing, Y; Yu, D; Zhang, J1
Azman, M; Kılıç, R; Muluk, NB; Simsek, G; Taş, BM1
Lai, L; Lin, H; Pang, J; Su, Z; Xiong, H; Zhang, H; Zhang, W; Zheng, Y1
Bermúdez-Muñoz, JM; García-Alcántara, F; Martínez-Vega, R; Milo, M; Murillo-Cuesta, S; Pulido, S; Rivera, T; Varela-Nieto, I1
Avcı, D; Erkan, M; Güleç, Ş; Gündoğdu, R; Güneş, MS; Karabulut, D; Kökoğlu, K; Sönmez, MF1
Akin, I; Besalti, O; Caliskan, M; Simşek, G; Tokgoz, SA; Vuralkan, E1

Other Studies

6 other study(ies) available for resveratrol and Deafness, Transitory

ArticleYear
A reduced form of nicotinamide riboside protects the cochlea against aminoglycoside-induced ototoxicity by SIRT1 activation.
    Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie, 2022, Volume: 150

    Topics: 14-3-3 Proteins; Aminoglycosides; Animals; Anti-Bacterial Agents; Cochlea; Hearing Loss; Kanamycin; Mice; NAD; Niacinamide; Ototoxicity; Pyridinium Compounds; Reactive Oxygen Species; Resveratrol; Sirtuin 1

2022
Comparison of the protective efficacy between intratympanic dexamethasone and resveratrol treatments against cisplatin-induced ototoxicity: an experimental study.
    European archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery, 2019, Volume: 276, Issue:12

    Topics: Animals; Antineoplastic Agents; Cisplatin; Dexamethasone; Hearing Loss; Injection, Intratympanic; Male; Otoacoustic Emissions, Spontaneous; Ototoxicity; Rats; Resveratrol

2019
LncRNA AW112010 Promotes Mitochondrial Biogenesis and Hair Cell Survival: Implications for Age-Related Hearing Loss.
    Oxidative medicine and cellular longevity, 2019, Volume: 2019

    Topics: Adenosine Triphosphate; Aging; Animals; Cell Survival; DNA-Binding Proteins; Gene Silencing; Hair Cells, Auditory; Hearing Loss; Mice; Mitochondria; Organelle Biogenesis; Resveratrol; RNA, Long Noncoding; Signal Transduction; Transcription Factors

2019
The expression of oxidative stress response genes is modulated by a combination of resveratrol and N-acetylcysteine to ameliorate ototoxicity in the rat cochlea.
    Hearing research, 2018, Volume: 358

    Topics: Acetylcysteine; Animals; Antioxidants; Apoptosis; Auditory Fatigue; Brain Stem; Cochlea; Cytoprotection; Disease Models, Animal; Drug Therapy, Combination; Evoked Potentials, Auditory, Brain Stem; Furosemide; Gene Expression Regulation; Hearing; Hearing Loss; Inflammation Mediators; Kanamycin; Male; Oxidative Stress; Rats, Wistar; Reaction Time; Resveratrol

2018
A Prospective Experimental Study on the Protective Effect of Resveratrol against Amikacin-Induced Ototoxicity in Rats.
    The journal of international advanced otology, 2016, Volume: 12, Issue:3

    Topics: Amikacin; Animals; Anti-Bacterial Agents; Antioxidants; Disease Models, Animal; Female; Hearing Loss; Otoacoustic Emissions, Spontaneous; Rats; Rats, Sprague-Dawley; Resveratrol; Stilbenes

2016
Protective effects of resveratrol on cisplatin-dependent inner-ear damage in rats.
    European archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery, 2013, Volume: 270, Issue:6

    Topics: Animals; Antineoplastic Agents; Cisplatin; Hearing Loss; Male; Random Allocation; Rats; Rats, Wistar; Resveratrol; Stilbenes

2013